Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Alliance Grants

University of Toronto

$555,285.00

Picosecond InfraRed Laser (PIRL) Technology: The Fundamental Limit to Minimally Invasive Surgery with Complete Biodiagnostics for Surgical Guidance

FY 2024-25

Summary
The fundamental single cell limit to minimally invasive surgery has been achieved with the Picosecond InfraRed Laser (PIRL) scalpel - without scar tissue formation and with complete molecular signatures of excised tissue remaining perfectly intact. The basic physics of this unique tool involve the selective excitation of water vibrations and direct coupling to translational motions to drive ablation processes faster than energy loss to surrounding tissue and associated collateral damage or thermal modification of the molecular composition of the tissue being excised. One obtains an instant snapshot of the molecular fingerprints of the tissue to know exactly what tissue is being cut. If the wrong tissue is removed, the surgery is hardly minimally invasive. PIRL provides molecular level information for identifying cancer borders, disease states, and completely avoids damage to healthy tissue. Healing is found to occur with no visible scar tissue formation. Scar tissue is not only cosmetically undesirable but also limits the efficacy for all surgical procedures. This feature holds the prospect for full recovery of function and with the associated reduced health care costs. The proposed research will develop the next generation of PIRL surgical systems that will provide single cell accuracy at speeds comparable to the highest speed surgical tools in the OR. All fiber beam delivery systems will also be developed that will enable access to different parts of the body with entry wound sizes of only 200 microns (dimensions of a single hair) for removing cancers, biopsies, disease tissue with absolutely minimal trauma. On the basic science front, this research program will increase the sensitivity of spatial imaging mass spectrometry (MS) by exploiting the intact molecular signatures and high collection efficiency inherent to the PIRL ablation process to push towards single cell resolution to directly map biochemical pathways leading to cell functions and onset of disease states. This objective will additionally provide the tissue specific molecular information for surgical guidance and given the sensitivity of MS, represent the ultimate limit to biodiagnostics for the detection of diseases at the earliest possible stage.
Program
Alliance Grants
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
567104-2021
Name nom
Miller, R J Dwayne RJD
Department département
Chemistry (St. George Campus)
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2021
Award amount
555285
Program id
ALLRP
Program name en
Alliance Grants
Program name fr
Subventions Alliance
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1211
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Medical and health sciences
Area of application fr
Sciences médicales et de la santé
Research subject code
1901
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical technology
Research subject fr
Technologie biomédicale
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Picosecond InfraRed Laser (PIRL) Technology: The Fundamental Limit to Minimally Invasive Surgery with Complete Biodiagnostics for Surgical Guidance
Keywords
cancer detection; disease proteomes; in situ healing studies; laser surgery at single cell limit; molecular fingerprints of tissue; molecular signature of disease; power scaling/universal tool for or; scar free; tissue data bank; tissue proteomes
Application summary
The fundamental single cell limit to minimally invasive surgery has been achieved with the Picosecond InfraRed Laser (PIRL) scalpel - without scar tissue formation and with complete molecular signatures of excised tissue remaining perfectly intact. The basic physics of this unique tool involve the selective excitation of water vibrations and direct coupling to translational motions to drive ablation processes faster than energy loss to surrounding tissue and associated collateral damage or thermal modification of the molecular composition of the tissue being excised. One obtains an instant snapshot of the molecular fingerprints of the tissue to know exactly what tissue is being cut. If the wrong tissue is removed, the surgery is hardly minimally invasive. PIRL provides molecular level information for identifying cancer borders, disease states, and completely avoids damage to healthy tissue. Healing is found to occur with no visible scar tissue formation. Scar tissue is not only cosmetically undesirable but also limits the efficacy for all surgical procedures. This feature holds the prospect for full recovery of function and with the associated reduced health care costs. The proposed research will develop the next generation of PIRL surgical systems that will provide single cell accuracy at speeds comparable to the highest speed surgical tools in the OR. All fiber beam delivery systems will also be developed that will enable access to different parts of the body with entry wound sizes of only 200 microns (dimensions of a single hair) for removing cancers, biopsies, disease tissue with absolutely minimal trauma. On the basic science front, this research program will increase the sensitivity of spatial imaging mass spectrometry (MS) by exploiting the intact molecular signatures and high collection efficiency inherent to the PIRL ablation process to push towards single cell resolution to directly map biochemical pathways leading to cell functions and onset of disease states. This objective will additionally provide the tissue specific molecular information for surgical guidance and given the sensitivity of MS, represent the ultimate limit to biodiagnostics for the detection of diseases at the earliest possible stage.
University of Toronto - $555,285 Grant (2024-25) | Canada Spends